On Friday, Shares of Uranium Resources, Inc. (NASDAQ:URRE), remained flat and closed at $1.28 in the last trading session. The last trading range of the stock ranges between $1.27 and $1.32. Uranium Resources, Inc. (URI) (URRE) (ASX:URI), declared recently that it has entered an amendment letter to extend its agreement with Laramide Resources Ltd. (Laramide) to sell URI’s Churchrock and Crownpoint properties in New Mexico until November 30, 2016 in exchange for an extension payment of $250,000 US in cash payable to URI on or before October 21, 2016.
Laramide formerly agreed to purchase the Churchrock and Crownpoint properties for $12.5 million under certain terms and conditions formerly declared. Other than an extension of the date by which either party could terminate that Agreement from September 30, 2016 to November 30, 2016, no further changes are made to the Share Purchase Agreement dated April 7, 2016 filed with the SEC as Exhibit 2.1 to URI’s Form 8-K filed on April 8, 2016. The $250,000 to be paid on or before October 21, 2016 will be treated as a pre-payment of the $12.5 million purchase price once the transaction closes, and will not be refunded nor credited under any other circumstances.
Baxter International Inc (NYSE:BAX), dropped -0.57% and closed at $47.45 in the last trading session. The last trading range of the stock ranges between $47.38 and $48.25. The company’s Market capitalization is $25.66 Billion with the total outstanding Shares of 543.89 million. Baxter International Inc. (BAX), a global leader in PN therapy, partnered with the American Society for Parenteral and Enteral Nutrition (ASPEN) and the Agency for Healthcare Research and Quality (AHRQ) to co-author a new statistical brief – ”Characteristics of Hospital Stays Involving Malnutrition, 2013” – about the often overlooked consequences of disease-related malnutrition.
The new statistical data characterizes the impact of malnutrition in U.S. hospitalized patients in human and economic costs – concluding malnutrition is associated with up to five times higher risk of in-hospital deaths, may result in two times longer hospital stays, and creates an estimated $42 billion1 burden to the healthcare system.
”I believe the fundamental reason malnutrition is underdiagnosed and undertreated is that we lack objective, measurable means to diagnose the condition,” said Paul Wischmeyer, M.D., E.D.I.C., Department of Anesthesiology and Duke Clinical Research Institute, Duke University Medical Center. ”I teach that nutrition assessment has to occur in every patient, and at-risk patients should be started on thoughtful nutrition therapy within 48 hours.”
Home Depot Inc (NYSE:HD), gained 0.10% and closed at $126.42 in the last trading session. The last trading range of the stock ranges between $126.42 and $127.56. The company’s Market capitalization is $156.36 Billion with the total outstanding Shares of 1.24 billion. During the 52-week trading session the minimum price at which share price traded, registered at $109.62 and reached to max level of $139.00. The Home Depot®, the world’s leading home improvement retailer, recently declared the appointment of Jeff Boyd, interim chief executive officer and president of The Priceline Group, Inc. (“Priceline”), to the company’s board of directors. Boyd will serve on the company’s Nominating and Corporate Governance Committee and its Finance Committee. His appointment gives the company 13 directors, 12 of whom are independent.
Boyd has served in a number of senior executive positions during his tenure at Priceline, a leading provider of online travel and related services. His planned leadership at Priceline guided the company to grow from a loss in 2002 to a multi-billion dollar profitable business.
Boyd has served as Priceline’s interim CEO and president since April 2016, and has served as its chairman since January 2013. He formerly served in a number of roles of increasing responsibility at Priceline, counting as its president and CEO from November 2002 until December 2013. He was Priceline’s president and Co-CEO from August 2002 to November 2002; its chief operating officer from November 2000 to August 2002; and its executive vice president, general counsel and secretary from January 2000 to October 2000. Before joining Priceline, Boyd was executive vice president, general counsel and secretary of Oxford Health Plans, Inc.